Dr. Zhang has 20 years of experience in the biotech field managing emerging biotech companies and in venture capital. He is currently the President of Dynal Biotech (Beijing) Ltd., a wholly owned subsidy of Invitrogen Corporation. He was a postdoctoral fellow at Yale University School of Medicine. Dr. Zhang received Ph.D. from Simon Fraser University, his MBA from the University of Chicago and a B.S. from Huazhong Agricultural University.